These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 3932176

  • 1. Hormonal regulation of prolactin release by human prolactinoma cells cultured in serum-free conditions.
    Jaquet P, Gunz G, Grisoli F.
    Horm Res; 1985; 22(3):153-63. PubMed ID: 3932176
    [Abstract] [Full Text] [Related]

  • 2. A human pituitary adenoma secreting thyrotropin and prolactin: immunohistochemical, biochemical, and cell culture studies.
    Jaquet P, Hassoun J, Delori P, Gunz G, Grisoli F, Weintraub BD.
    J Clin Endocrinol Metab; 1984 Nov; 59(5):817-24. PubMed ID: 6480809
    [Abstract] [Full Text] [Related]

  • 3. On the functional relationship between 45Ca2+ release and prolactin secretion in cultured rat pituitary tumour (GH3) cells.
    Iversen JG, Sletholt K, Haug E, Gautvik KM.
    Acta Physiol Scand; 1986 Jun; 127(2):249-55. PubMed ID: 2873712
    [Abstract] [Full Text] [Related]

  • 4. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M, Yamaji T.
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [Abstract] [Full Text] [Related]

  • 5. Prolactin secretion after surgery or bromocriptine treatment of prolactinoma.
    De Leo V, Petraglia F, Sardelli S, Danero S, Genazzani AR, D'Antona N.
    Obstet Gynecol; 1987 Jan; 69(1):99-103. PubMed ID: 3099236
    [Abstract] [Full Text] [Related]

  • 6. Normal and adenomatous human pituitaries secrete thyrotropin-releasing hormone in vitro: modulation by dopamine, haloperidol, and somatostatin.
    Le Dafniet M, Lefebvre P, Barret A, Mechain C, Feinstein MC, Brandi AM, Peillon F.
    J Clin Endocrinol Metab; 1990 Aug; 71(2):480-6. PubMed ID: 1974264
    [Abstract] [Full Text] [Related]

  • 7. Perifusion studies of bromocriptine-treated and untreated macroprolactinomas: effects of dopamine, bromocriptine and TRH.
    Bevan JS, Burke CW.
    Clin Endocrinol (Oxf); 1989 Jun; 30(6):667-80. PubMed ID: 2512041
    [Abstract] [Full Text] [Related]

  • 8. Autoparacrine action of vasoactive intestinal peptide on dopaminergic control of prolactin secretion.
    Balsa JA, Sánchez-Franco F, Lorenzo MJ, Pazos F, Lara JI, Cacicedo L.
    Endocrinology; 1996 Feb; 137(2):508-13. PubMed ID: 8593796
    [Abstract] [Full Text] [Related]

  • 9. Transient dopaminergic inhibition of prolactin release from hybrid cells derived by fusion of normal rat pituitary and GH4C1 tumor cells.
    Day RN, Hinkle PM.
    Endocrinology; 1988 May; 122(5):2165-73. PubMed ID: 3129281
    [Abstract] [Full Text] [Related]

  • 10. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M, Yamaji T.
    J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
    [Abstract] [Full Text] [Related]

  • 11. Effect of thyrotropin-releasing hormone and bromoergocriptine on growth hormone and prolactin secretion in perfused pituitary adenoma tissues of acromegaly.
    Ishibashi M, Yamaji T.
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1251-6. PubMed ID: 122426
    [Abstract] [Full Text] [Related]

  • 12. Characteristics of prolactin-releasing response to salsolinol (SAL) and thyrotropin-releasing hormone (TRH) in ruminants.
    Hashizume T, Onodera Y, Shida R, Isobe E, Suzuki S, Sawai K, Kasuya E, Nagy GM.
    Domest Anim Endocrinol; 2009 Feb; 36(2):99-104. PubMed ID: 19070987
    [Abstract] [Full Text] [Related]

  • 13. Thyrotropin-releasing hormone rapidly stimulates a biphasic secretion of prolactin and growth hormone in GH4C1 rat pituitary tumor cells.
    Aizawa T, Hinkle PM.
    Endocrinology; 1985 Jan; 116(1):73-82. PubMed ID: 3917255
    [Abstract] [Full Text] [Related]

  • 14. Role of vasoactive intestinal peptide and 5-HT2 receptor subtype in serotonin stimulation of basal and thyrotropin-releasing-hormone-induced prolactin release in vitro from rat pituitary cells.
    Apfelbaum ME.
    Neuroendocrinology; 1998 Jan; 67(1):45-50. PubMed ID: 9485168
    [Abstract] [Full Text] [Related]

  • 15. Differences in the interaction between dopamine and estradiol on prolactin release by cultured normal and tumorous human pituitary cells.
    Lamberts SW, Verleun T, Hofland L, Oosterom R.
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1342-7. PubMed ID: 3782422
    [Abstract] [Full Text] [Related]

  • 16. Induction of hypothyroidism and hypoprolactinemia by growth hormone producing rat pituitary tumors.
    Seo H, Refetoff S, Fang VS.
    Endocrinology; 1977 Jan; 100(1):216-26. PubMed ID: 401484
    [Abstract] [Full Text] [Related]

  • 17. Serum prolactin and growth hormone response to thyrotropin-releasing hormone in patients with pituitary adenomas.
    Chang CC, Chen FW, Hsieh HC.
    Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):443-9. PubMed ID: 2507734
    [Abstract] [Full Text] [Related]

  • 18. Effects of sex steroids on prolactin secreting rat pituitary cells in culture.
    Haug E, Gautvik KM.
    Endocrinology; 1976 Dec; 99(6):1482-9. PubMed ID: 826392
    [Abstract] [Full Text] [Related]

  • 19. Prolactin (PRL)-releasing peptide stimulates PRL secretion from human fetal pituitary cultures and growth hormone release from cultured pituitary adenomas.
    Rubinek T, Hadani M, Barkai G, Melmed S, Shimon I.
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2826-30. PubMed ID: 11397894
    [Abstract] [Full Text] [Related]

  • 20. In vitro Effects of 17Beta-Estradiol on Thyrotropin-Releasing Hormone-Induced and Dopamine-lnhibited Prolactin Release from Adult Male Rat Lactotrophs in Primary Culture.
    Zhang J, Chen C, Kukstas LA, Verrier D, Vincent JD, Israel JM.
    J Neuroendocrinol; 1990 Jun 01; 2(3):277-84. PubMed ID: 19215347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.